HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letitia Weigand Selected Research

1- (2- (3- (4- methoxyphenyl)propoxy)- 4- methoxyphenylethyl)- 1H- imidazole

7/2005Inhibition of hypoxic pulmonary vasoconstriction by antagonists of store-operated Ca2+ and nonselective cation channels.
6/2005Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Letitia Weigand Research Topics

Disease

6Hypoxia (Hypoxemia)
09/2011 - 06/2005
2Pulmonary Hypertension
06/2006 - 02/2006

Drug/Important Bio-Agent (IBA)

2Y 27632IBA
09/2011 - 09/2007
2Nifedipine (Adalat)FDA LinkGeneric
07/2005 - 06/2005
21- (2- (3- (4- methoxyphenyl)propoxy)- 4- methoxyphenylethyl)- 1H- imidazoleIBA
07/2005 - 06/2005
1rho-Associated KinasesIBA
09/2011
1CalciumIBA
09/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011
1fasudil (AT 877)IBA
09/2007
1ML 9IBA
09/2007
1ML 7IBA
09/2007
1Hypoxia-Inducible Factor 1IBA
06/2006
1Transcription Factors (Transcription Factor)IBA
06/2006
1Endothelin-1 (Endothelin 1)IBA
02/2006
1Vasoconstrictor AgentsIBA
02/2006
1Bicarbonates (Hydrogen Carbonate)IBA
06/2005
1cyclopiazonic acidIBA
06/2005
1Proteins (Proteins, Gene)FDA Link
06/2005
1Messenger RNA (mRNA)IBA
06/2005
1SaltsIBA
06/2005
1SolutionsIBA
06/2005
1Fura-2 (Fura 2)IBA
06/2005